Identification of the flavivirus conserved residues in the envelope protein hinge region for the rational design of a candidate West Nile live-attenuated vaccine

被引:0
|
作者
Maloney, Bailey E. [1 ,2 ]
Carpio, Kassandra L. [3 ,4 ]
Bilyeu, Ashley N. [1 ,2 ]
Saunders, Danielle R. D. [1 ,2 ,7 ]
Park, So Lee [1 ,2 ]
Pohl, Adrienne E. [1 ,2 ]
Ball, Natalia Costa [1 ,2 ]
Raetz, Janae L. [5 ]
Huang, Claire Y. [5 ]
Higgs, Stephen [1 ,2 ]
Barrett, Alan D. T. [4 ,6 ]
Roman-Sosa, Gleyder [1 ,8 ]
Kenney, Joanie L. [5 ]
Vanlandingham, Dana L. [1 ,2 ]
Huang, Yan-Jang S. [1 ,2 ,9 ,10 ]
机构
[1] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA
[2] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA
[3] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA
[4] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA
[5] Ctr Dis Control & Prevent, Div Vector borne Dis, Ft Collins, CO 80521 USA
[6] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA
[7] US Acad, Dept Biol, Colorado Springs, CO 80840 USA
[8] Univ Vet Med Hanover, Inst Virol, Buentewg 17, D-30559 Hannover, Germany
[9] Upstate Med Univ, Inst Global Hlth & Translat Sci, Dept Microbiol & Immunol, Syracuse, NY 13210 USA
[10] Upstate Med Univ, Inst Global Hlth & Translat Sci, SUNY Ctr Vector Borne Dis, Syracuse, NY 13210 USA
基金
美国国家卫生研究院;
关键词
YELLOW-FEVER VIRUS; JAPANESE ENCEPHALITIS-VIRUS; DENGUE VIRUS; NS1; PROTEIN; GLYCOPROTEIN; REPLICATION; VIRULENCE; STRAIN; SAFETY; NEUROINVASIVENESS;
D O I
10.1038/s41541-023-00765-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The flavivirus envelope protein is a class II fusion protein that drives flavivirus-cell membrane fusion. The membrane fusion process is triggered by the conformational change of the E protein from dimer in the virion to trimer, which involves the rearrangement of three domains, EDI, EDII, and EDIII. The movement between EDI and EDII initiates the formation of the E protein trimer. The EDI-EDII hinge region utilizes four motifs to exert the hinge effect at the interdomain region and is crucial for the membrane fusion activity of the E protein. Using West Nile virus (WNV) NY99 strain derived from an infectious clone, we investigated the role of eight flavivirus-conserved hydrophobic residues in the EDI-EDII hinge region in the conformational change of E protein from dimer to trimer and viral entry. Single mutations of the E-A54, E-I130, E-I135, E-I196, and E-Y201 residues affected infectivity. Importantly, the E-A54I and E-Y201P mutations fully attenuated the mouse neuroinvasive phenotype of WNV. The results suggest that multiple flavivirus-conserved hydrophobic residues in the EDI-EDII hinge region play a critical role in the structure-function of the E protein and some contribute to the virulence phenotype of flaviviruses as demonstrated by the attenuation of the mouse neuroinvasive phenotype of WNV. Thus, as a proof of concept, residues in the EDI-EDII hinge region are proposed targets to engineer attenuating mutations for inclusion in the rational design of candidate live-attenuated flavivirus vaccines.
引用
收藏
页数:13
相关论文
共 34 条
  • [21] Development of a human live attenuated West Nile infectious DNA vaccine: Identification of a minimal mutation set conferring the attenuation level acceptable for a human vaccine
    Yamshchikov, Vladimir
    Manuvakhova, Marina
    Rodriguez, Efrain
    Hebert, Charles
    VIROLOGY, 2017, 500 : 122 - 129
  • [22] A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Δ30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers
    Pierce, Kristen K.
    Whitehead, Stephen S.
    Kirkpatrick, Beth D.
    Grier, Palmtama L.
    Jarvis, Adrienne
    Kenney, Heather
    Carmolli, Marya P.
    Reynolds, Cynthia
    Tibery, Cecilia M.
    Lovchik, Janece
    Janiak, Anna
    Luke, Catherine J.
    Durbin, Anna P.
    Pletnev, Alexander G.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (01): : 52 - 55
  • [23] An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development
    Yamshchikov, G
    Borisevich, V
    Seregin, A
    Chaporgina, E
    Mishina, M
    Mishin, V
    Kwok, CW
    Yamshchikov, V
    VIROLOGY, 2004, 330 (01) : 304 - 312
  • [24] Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children
    McFarland, Elizabeth J.
    Karron, Ruth A.
    Muresan, Petronella
    Cunningham, Coleen K.
    Valentine, Megan E.
    Perlowski, Charlotte
    Thumar, Bhagvanji
    Gnanashanmugam, Devasena
    Siberry, George K.
    Schappell, Elizabeth
    Barr, Emily
    Rexroad, Vivian
    Yogev, Ram
    Spector, Stephen A.
    Aziz, Mariam
    Patel, Nehali
    Cielo, Mikhaela
    Luongo, Cindy
    Collins, Peter L.
    Buchholz, Ursula J.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (09): : 1347 - 1355
  • [25] A one-health approach to design an mRNA-based vaccine candidate against the lumpy skin disease virus as an alternative to live-attenuated vaccines
    Naveed, M.
    Hassan, J.
    Aziz, T.
    Ali, U.
    Rana, I. K.
    Khan, A. Ali
    Fakhrul, H.
    Alharbi, M.
    Alshammari, A.
    Alasmari, A. F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (13) : 6401 - 6413
  • [26] Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues
    Rostad, Christina A.
    Stobart, Christopher C.
    Todd, Sean O.
    Molina, Samuel A.
    Lee, Sujin
    Blanco, Jorge C. G.
    Moore, Martin L.
    JOURNAL OF VIROLOGY, 2018, 92 (06)
  • [27] Development of a human live attenuated West Nile infectious DNA vaccine: Suitability of attenuating mutations found in SA14-14-2 for WN vaccine design
    Yamshchikov, Vladimir
    Manuvakhova, Marina
    Rodriguez, Efrain
    VIROLOGY, 2016, 487 : 198 - 206
  • [28] Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein
    Alamares-Sapuay, Judith
    Kishko, Michael
    Lai, Charles
    Parrington, Mark
    Delagrave, Simon
    Herbert, Richard
    Castens, Ashley
    Swerczek, Joanna
    Luongo, Cindy
    Yang, Lijuan
    Collins, Peter L.
    Buchholz, Ursula J.
    Zhang, Linong
    PLOS ONE, 2024, 19 (04):
  • [29] The two amino acid substitutions in the L protein of cpts530/1009, a live-attenuated respiratory syncytial virus candidate vaccine, are independent temperature-sensitive and attenuation mutations
    Juhasz, K
    Whitehead, SS
    Boulanger, CA
    Firestone, CY
    Collins, PL
    Murphy, BR
    VACCINE, 1999, 17 (11-12) : 1416 - 1424
  • [30] Rational design of live attenuated vaccine by site-directed mutagenesis and deletion in the 50-non coding region of the Enterovirus 71 (EV71) genome
    Yee, P. T.
    Onn, Kuan T.
    Laa, Chit P.
    ALLERGY, 2015, 70 : 635 - 635